BIOMARIN PHARMACEUTICAL INC.

• BIOMARIN PHARMACEUTICAL INC. $2,390,000 7 filings

• DANIEL MAYNE 3 filings · through 2026 SENIOR REGULATORY HEALTH CONSULTANT- FOOD & DRUG ADMINISTRATION (6/2020-2/2022); REGULATORY POLICY ANALYST- FOOD & DRUG ADMINISTRATION (9/2023-6/2024)

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

• 2026 $1,070,000 3 filings
• 2025 $1,320,000 4 filings

• Health Issues 7
• Medicare/Medicaid 7
• Tariff (miscellaneous tariff bills) 7
• Taxation/Internal Revenue Code 5
• Budget/Appropriations 2
• Medical/Disease Research/Clinical Labs 2
• Copyright/Patent/Trademark 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 7
• SENATE 7
• Commerce, Dept of (DOC) 4
• Health & Human Services, Dept of (HHS) 3
• Food & Drug Administration (FDA) 2
• Centers For Medicare and Medicaid Services (CMS) 1
• Executive Office of the President (EOP) 1
• Health Resources & Services Administration (HRSA) 1